Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030107 · ClinicalTrials.gov registry record
Effects of Sleep Duration on Eating and Activity Behaviors
A clinical trial, sponsored by The Miriam Hospital.
- Completed
- Registry status
- 37
- Enrollment target
NCT01030107: Completed study, sponsored by The Miriam Hospital.
NCT01030107 is a clinical trial that has completed, run by The Miriam Hospital. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01030107 has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to determine whether the amount children sleep is associated with changes in hormones, hunger, motivation to eat, and food intake. Fifty children 8-11 years old who sleep 9-10 hours per night will be enrolled for a 3-week study. For 1 week each, children will be asked to sleep their typical amount, increase their sleep by 1-½ hours, and decrease their sleep by 1-½ hours. Half of the children will be asked to increase their sleep first and half to decrease their sleep first. During each week, the following will be gathered: sleep duration (measured by actigraphy, which is a small device that measures sleep), levels of hormones measured through blood draws, self-reported hunger and appetite, food intake (measured by 3 days of 24-hour recall), how motivated children are to eat (measured using a computer activity), and child height and weight. We believe that when children sleep less they will show changes in hormones associated with hunger and appetite, report being hungrier, be more motivated to eat, and eat more food.
Interventions
- BEHAVIORAL Increase Sleep
- BEHAVIORAL Decrease Sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-01 |
What the finished NCT01030107 record still lists
NCT01030107 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Increase Sleep is the first listed.
NCT01030107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01030107 about?
NCT01030107 is a clinical study titled "Effects of Sleep Duration on Eating and Activity Behaviors". The purpose of the proposed study is to determine whether the amount children sleep is associated with changes in hormones, hunger, motivation to eat, and food intake. Fifty children 8-11 years old who sleep 9-10 hours per night will be enrolled for a 3-week study. For 1 week each, children will be ...
What is the current status of trial NCT01030107?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2009-02. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01030107?
The interventions under investigation include: Increase Sleep (BEHAVIORAL), Decrease Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT01030107?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia